Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 39.01%1.71B | 25.21%2.63B | 17.65%1.23B | -8.81%2.1B | -11.55%1.05B | 9.66%2.3B | 16.62%1.18B | 21.51%2.1B | 4.31%1.02B | -27.94%1.73B |
| Operating income | 39.01%1.71B | 25.21%2.63B | 17.65%1.23B | -8.81%2.1B | -11.55%1.05B | 9.66%2.3B | 16.62%1.18B | 21.51%2.1B | 4.31%1.02B | -27.94%1.73B |
| Cost of sales | -40.23%-1.54B | -27.64%-2.39B | -19.75%-1.1B | 9.26%-1.87B | 11.38%-914.68M | -12.62%-2.07B | -18.17%-1.03B | -23.64%-1.83B | -3.09%-873.46M | 27.89%-1.48B |
| Operating expenses | -40.23%-1.54B | -27.64%-2.39B | -19.75%-1.1B | 9.26%-1.87B | 11.38%-914.68M | -12.62%-2.07B | -18.17%-1.03B | -23.64%-1.83B | -3.09%-873.46M | 27.89%-1.48B |
| Gross profit | 29.22%176.66M | 4.82%234.04M | 3.17%136.71M | -4.78%223.27M | -12.65%132.51M | -10.95%234.48M | 7.06%151.7M | 8.47%263.32M | 12.56%141.69M | -28.23%242.75M |
| Selling expenses | -151.36%-38.38M | -24.71%-32.11M | -34.48%-15.27M | -32.93%-25.75M | -18.81%-11.36M | -29.14%-19.37M | -16.72%-9.56M | 8.96%-15M | -7.16%-8.19M | 47.92%-16.48M |
| Administrative expenses | -13.92%-28.06M | -1.54%-51.16M | 2.62%-24.63M | 4.56%-50.39M | 19.37%-25.29M | -14.02%-52.79M | -23.29%-31.36M | -14.60%-46.3M | -23.19%-25.44M | 18.86%-40.4M |
| Research and development expenses | -25.80%-38.46M | -15.22%-92.94M | -11.92%-30.57M | 6.42%-80.66M | 3.43%-27.31M | -28.58%-86.19M | -4.21%-28.28M | 8.85%-67.04M | -14.62%-27.14M | -61.92%-73.54M |
| Impairment and provision | 56.88%-2.25M | -14.79%-24.49M | -9.09%-5.22M | 88.81%-21.33M | -20.63%-4.78M | -409.98%-190.74M | ---3.97M | ---37.4M | ---- | ---- |
| -Goodwill impairment | ---- | -1,001.95%-26.02M | ---- | 98.47%-2.36M | ---- | ---154.79M | ---- | ---- | ---- | ---- |
| -Other impairment is provision | 56.88%-2.25M | 108.05%1.53M | -9.09%-5.22M | 47.22%-18.97M | -20.63%-4.78M | 3.88%-35.95M | ---3.97M | ---37.4M | ---- | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---3.43M | ---7.55M | ---- | ---- |
| Special items of operating profit | -77.06%409K | -144.95%-1.36M | 141.73%1.78M | -80.08%3.03M | -4,755.68%-4.27M | 813.86%15.2M | 97.98%-88K | 87.63%-2.13M | -473.07%-4.35M | 51.65%-17.21M |
| Operating profit | 11.33%69.93M | -33.62%31.97M | 5.58%62.81M | 148.45%48.17M | -20.69%59.49M | -213.11%-99.42M | -2.04%75.01M | -7.59%87.9M | 1.99%76.57M | -45.89%95.12M |
| Financing cost | -41.48%-8.44M | -45.48%-14.56M | -25.07%-5.97M | -30.05%-10.01M | ---4.77M | ---7.7M | ---- | ---- | 30.62%-3.77M | 22.48%-10.17M |
| Share of profits of associates | ---- | 71.79%-1M | ---- | 18.26%-3.55M | -11.97%-2.26M | -13.36%-4.34M | -17.56%-2.02M | -156.78%-3.83M | -453.05%-1.72M | ---1.49M |
| Earning before tax | 8.16%61.48M | -52.58%16.41M | 8.36%56.84M | 131.06%34.61M | -28.13%52.46M | -232.57%-111.45M | 2.68%72.99M | 0.74%84.07M | 2.52%71.08M | -48.69%83.46M |
| Tax | 1.81%-9.67M | 30.09%-8.82M | -4.67%-9.85M | 26.24%-12.62M | 33.93%-9.41M | 21.45%-17.11M | 1.65%-14.25M | -30.85%-21.78M | 4.17%-14.48M | 70.76%-16.64M |
| After-tax profit from continuing operations | 10.26%51.81M | -65.48%7.59M | 9.17%46.99M | 117.11%22M | -26.72%43.05M | -306.36%-128.56M | 3.79%58.74M | -6.76%62.3M | 4.39%56.6M | -36.81%66.81M |
| Earning after tax | 10.26%51.81M | -65.48%7.59M | 9.17%46.99M | 117.11%22M | -26.72%43.05M | -306.36%-128.56M | 3.79%58.74M | -6.76%62.3M | 4.39%56.6M | -36.81%66.81M |
| Minority profit | 14.46%2.42M | -18.18%5.33M | -18.71%2.12M | 564.76%6.51M | --2.6M | --979K | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 10.06%49.39M | -85.36%2.27M | 10.96%44.88M | 111.96%15.49M | -31.15%40.44M | -307.93%-129.54M | 3.79%58.74M | -6.76%62.3M | 4.39%56.6M | -36.81%66.81M |
| Basic earnings per share | 0.00%0.03 | -85.58%0.0015 | 0.00%0.03 | 111.56%0.0104 | -25.00%0.03 | -325.00%-0.09 | 0.00%0.04 | -20.00%0.04 | 0.00%0.04 | -44.44%0.05 |
| Diluted earnings per share | 0.00%0.03 | -85.29%0.0015 | 0.00%0.03 | 111.33%0.0102 | -25.00%0.03 | -325.00%-0.09 | 0.00%0.04 | -20.00%0.04 | 0.00%0.04 | -37.50%0.05 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.